Cargando…

Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome

BACKGROUND: We previously showed that stool samples of pre-adolescent and adolescent US children diagnosed with diarrhea-predominant IBS (IBS-D) had different compositions of microbiota and metabolites compared to healthy age-matched controls. Here we explored whether observed fecal microbiota and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shankar, Vijay, Reo, Nicholas V., Paliy, Oleg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675077/ https://www.ncbi.nlm.nih.gov/pubmed/26653757 http://dx.doi.org/10.1186/s40168-015-0139-9

Ejemplares similares

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome
por: Ahmed, Iftikhar, et al.
Publicado: (2013)

Differences in Gut Metabolites and Microbial Composition and Functions between Egyptian and U.S. Children Are Consistent with Their Diets
por: Shankar, V., et al.
Publicado: (2017)

The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021)

Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation
por: Shankar, Vijay, et al.
Publicado: (2014)

Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
por: Goepp, Julius, et al.
Publicado: (2014)

Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
por: Wang, Alice Yuxin, et al.
Publicado: (2016)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Analysis of brain networks and fecal metabolites reveals brain–gut alterations in premenopausal females with irritable bowel syndrome
por: Osadchiy, Vadim, et al.
Publicado: (2020)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Fecal Microbial Composition and Predicted Functional Profile in Irritable Bowel Syndrome Differ between Subtypes and Geographical Locations
por: Garcia-Mazcorro, Jose F., et al.
Publicado: (2023)

Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhu, Xue, et al.
Publicado: (2021)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Gut Microbial Metabolites and Biochemical Pathways Involved in Irritable Bowel Syndrome: Effects of Diet and Nutrition on the Microbiome
por: James, Shanalee C, et al.
Publicado: (2020)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
por: Xiao, Lin, et al.
Publicado: (2021)

Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome
por: Zhang, Wen-Xue, et al.
Publicado: (2019)

Advantages of phylogenetic distance based constrained ordination analyses for the examination of microbial communities
por: Shankar, V., et al.
Publicado: (2017)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome
por: Wang, Taojun, et al.
Publicado: (2022)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Microbial community and metabolomic comparison of irritable bowel syndrome faeces
por: Ponnusamy, Kannan, et al.
Publicado: (2011)

A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome
por: Peter, Johannes, et al.
Publicado: (2018)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

A53 FECAL BIOACTIVE PHOSPHOLIPIDS AS TRIGGERS OF INTESTINAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME
por: Pujo, J, et al.
Publicado: (2023)

Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis
por: Zhou, Xing-lu, et al.
Publicado: (2014)

Vitamin D status in pediatric irritable bowel syndrome
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2017)

Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019)

Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease
por: Yamamoto, Mai, et al.
Publicado: (2021)

Tryptophan Metabolites in Irritable Bowel Syndrome: An Overnight Time-course Study
por: Burr, Robert L, et al.
Publicado: (2019)

Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome
por: Zhu, Shengtao, et al.
Publicado: (2019)

Bowel management for the treatment of pediatric fecal incontinence
por: Bischoff, Andrea, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_i3m4v2osohvns77bl86bsl40dk